Aditya Birla Sun Life Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund
Aditya Birla Sun Life Pharma and Healthcare Fund and Tata India Pharma & Healthcare Fund are both Pharma & Healthcare Funds. As of 6 Nov 2026 (Direct plan, Growth option): 3-year CAGR +21.74% vs +19.57%, 5-year CAGR +15.53% vs +15.36%, volatility 14.44% vs 15.45%, maximum drawdown −20.46% vs −19.84%. Their portfolios overlap by 49.9% (26 stocks held by both).
Showing the Direct plan, Growth option. Portfolio, sector and market-cap figures are the same for every plan and option of a fund.
Key facts
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Fund house | Aditya Birla Sun Life Mutual Fund | Tata Mutual Fund |
| Compared as | Pharma & Healthcare Funds | Pharma & Healthcare Funds |
| NAV | ₹40.7600 | ₹38.9649 |
| NAV date | 6 Nov 2026 | 6 Nov 2026 |
| Launched (first NAV) | 11 Jul 2019 | 29 Dec 2015 |
| Track record | 7.3 yrs | 10.9 yrs |
| Fund size (AUM) | ₹1,078 Cr | ₹1,511 Cr |
| Securities held | 39 | 42 |
| Portfolio as of | 30 Sep 2026 | 30 Sep 2026 |
| Fund page | Full record → | Full record → |
Returns
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| 1 month | +3.61% | +3.00% |
| 3 months | +0.10% | −2.45% |
| 6 months | +11.03% | +5.55% |
| 1 year | +19.04% | +8.40% |
| 3 years (CAGR) | +21.74% | +19.57% |
| 5 years (CAGR) | +15.53% | +15.36% |
| 7 years (CAGR) | +21.20% | +21.93% |
| 10 years (CAGR) | — | +15.69% |
| Since launch (CAGR) | +21.07% | +13.31% |
| SIP return (XIRR, 5 years) ⓘ | +19.35% | +16.98% |
Up to one year: absolute return. Beyond one year: CAGR. Computed from each fund's own NAV history (AMFI), measured to the latest NAV.
Calendar-year returns
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| 2026 (year to date) | +20.31% | +10.16% |
| 2025 | −3.09% | −3.47% |
| 2024 | +37.69% | +42.48% |
| 2023 | +39.58% | +38.59% |
| 2022 | −11.31% | −6.64% |
| 2021 | +21.36% | +20.88% |
Risk
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Volatility (annualised) ⓘ | 14.44% | 15.45% |
| Downside volatility ⓘ | 8.48% | 9.95% |
| Sharpe ratio ⓘ | 1.06 | 0.85 |
| Sortino ratio ⓘ | 1.80 | 1.31 |
| Maximum drawdown ⓘ | −20.46% | −19.84% |
| Recovery from that fall | 13 months | 12 months |
| Current fall from peak | −1.14% | −2.97% |
| Rolling 1-year return: worst | −15.55% | −17.32% |
| Rolling 1-year return: median | +17.82% | +8.76% |
| Rolling 1-year return: best | +72.90% | +76.35% |
| Share of 1-year periods with a loss | 19.53% | 29.14% |
Against each fund's benchmark
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Beta ⓘ | 0.66 | 0.79 |
| Alpha (Jensen's, annualised) ⓘ | +11.17% | +9.19% |
| R² ⓘ | 45.21 | 56.03 |
| Upside capture | 106.22% | 109.89% |
| Downside capture | 46.88% | 62.37% |
| Tracking error | 12.55% | 11.45% |
| Information ratio | 0.89 | 0.81 |
| Treynor ratio | 22.46 | 16.33 |
Portfolio
Asset mix
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Equity | 97.94% | 99.72% |
| Cash & equivalents | 2.07% | 0.28% |
Market-cap split (share of fund assets)
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Large Cap | 32.94% | 26.01% |
| Mid Cap | 30.64% | 33.87% |
| Small Cap | 31.74% | 36.96% |
| Unclassified | 2.61% | 2.88% |
Concentration
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Top 10 holdings | 54.43% | 50.53% |
| Effective number of stocks ⓘ | 23.9 | 26.9 |
| Securities held | 39 | 42 |
Portfolio overlap: 49.9%
26 companies are held by both funds; by weight, 49.9% of the two portfolios is the same. That is a moderate overlap.
| Held by both | Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 8.61% | 7.99% |
| Apollo Hospitals Enterprise Limited | 6.44% | 4.36% |
| Cipla Limited | 6.38% | 4.22% |
| Torrent Pharmaceuticals Limited | 9.28% | 3.76% |
| Abbott India Limited | 3.26% | 5.94% |
| Lupin Limited | 2.94% | 3.14% |
| Sai Life Sciences Limited | 4.49% | 2.60% |
| Divi's Laboratories Limited | 2.24% | 5.68% |
| Fortis Healthcare Limited | 2.42% | 1.95% |
| Procter & Gamble Health Limited | 1.82% | 2.75% |
| Dr. Lal Path Labs Limited | 3.51% | 1.76% |
| Alkem Laboratories Limited | 1.68% | 2.36% |
| Ajanta Pharma Limited | 4.35% | 1.63% |
| Dr. Reddy's Laboratories Limited | 1.13% | 4.65% |
| Anthem Biosciences Limited | 1.13% | 2.57% |
Top 10 holdings
Aditya Birla Sun Life Pharma and Healthcare
- Torrent Pharmaceuticals Limited9.28%
- Sun Pharmaceutical Industries Limited8.61%
- Apollo Hospitals Enterprise Limited6.44%
- Cipla Limited6.38%
- Aurobindo Pharma Limited4.52%
- Sai Life Sciences Limited4.49%
- Ajanta Pharma Limited4.35%
- Mankind Pharma Limited3.62%
- Dr. Lal Path Labs Limited3.51%
- Abbott India Limited3.26%
Tata India Pharma & Healthcare
- Sun Pharmaceutical Industries Limited7.99%
- Abbott India Limited5.94%
- Healthcare Global Enterprises Limited5.92%
- Divi's Laboratories Limited5.68%
- Dr. Reddy's Laboratories Limited4.65%
- Apollo Hospitals Enterprise Limited4.36%
- Rainbow Childrens Medicare Limited4.30%
- Cipla Limited4.22%
- Torrent Pharmaceuticals Limited3.76%
- Max Healthcare Institute Limited3.71%
Sector exposure
| Aditya Birla Sun Life Pharma and Healthcare | Tata India Pharma & Healthcare | |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.91% | 60.64% |
| Healthcare Services | 21.61% | 27.79% |
| Fertilizers & Agrochemicals | 0.00% | 6.93% |
| Chemicals & Petrochemicals | 0.69% | 2.59% |
| Personal Products | 0.00% | 1.23% |
| Insurance | 0.73% | 0.00% |
| Healthcare Equipment & Supplies | 0.00% | 0.54% |
Questions people ask
What is the difference between Aditya Birla Sun Life Pharma and Healthcare and Tata India Pharma & Healthcare returns?
As of 6 Nov 2026, Direct plan Growth option: 1-year return +19.04% vs +8.40%; 3-year CAGR +21.74% vs +19.57%; 5-year CAGR +15.53% vs +15.36%; 10-year CAGR — vs +15.69%. Past returns do not indicate future returns.
How do Aditya Birla Sun Life Pharma and Healthcare and Tata India Pharma & Healthcare compare on risk?
Volatility (36 monthly returns, annualised) 14.44% vs 15.45%; Sharpe ratio 1.06 vs 0.85; Sortino ratio 1.80 vs 1.31; maximum drawdown −20.46% vs −19.84%; beta 0.66 vs 0.79.
How much do Aditya Birla Sun Life Pharma and Healthcare and Tata India Pharma & Healthcare overlap?
By weight, 49.9% of the two portfolios is invested in the same companies; 26 stocks are held by both, the largest shared positions being Sun Pharmaceutical Industries Limited, Apollo Hospitals Enterprise Limited, Cipla Limited. Based on the portfolios disclosed for Sep 2026 and Sep 2026.
What is the large, mid and small cap split of Aditya Birla Sun Life Pharma and Healthcare and Tata India Pharma & Healthcare?
Aditya Birla Sun Life Pharma and Healthcare: large cap 32.9%, mid cap 30.6%, small cap 31.7%. Tata India Pharma & Healthcare: large cap 26.0%, mid cap 33.9%, small cap 37.0% (share of the fund's assets, from its latest disclosed portfolio).
Is this a recommendation to choose one of these funds?
No. This page places the published figures of both funds side by side. It does not rank, rate or recommend either fund; which one suits an investor depends on their goals, horizon and risk tolerance.
More comparisons
Aditya Birla Sun Life Pharma and Healthcare vs
- Aditya Birla Sun Life Pharma and Healthcare vs Bajaj Finserv Healthcare
- Aditya Birla Sun Life Pharma and Healthcare vs ITI Pharma and Healthcare
- Aditya Birla Sun Life Pharma and Healthcare vs SBI HEALTHCARE OPPORTUNITIES
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Pharma and Healthcare
- Aditya Birla Sun Life Pharma and Healthcare vs Nippon India Pharma
- Aditya Birla Sun Life Pharma and Healthcare vs Bandhan Healthcare
Tata India Pharma & Healthcare vs
- Tata India Pharma & Healthcare vs Invesco India Pharma and Healthcare
- Tata India Pharma & Healthcare vs quant Healthcare
- Tata India Pharma & Healthcare vs DSP Healthcare
- Tata India Pharma & Healthcare vs Mirae Asset Healthcare
- Tata India Pharma & Healthcare vs Bajaj Finserv Healthcare
- Tata India Pharma & Healthcare vs ITI Pharma and Healthcare
All Pharma & Healthcare Funds comparisons → · Compare up to six funds yourself → · Every fund in this category → · All comparisons →
Sources: NAV from AMFI; returns, risk and ratios computed by MF Analyser from each fund's NAV history (risk on 36 monthly returns, risk-free rate 6.5%); benchmark ratios against each fund's benchmark total-return index; portfolios from each fund house's monthly disclosure. Returns and ratios as of 6 Nov 2026. IDCW options show no return or risk figures because payouts reduce the NAV and AMFI's file carries no payout history to add back. This page compares published figures only — it does not rank, rate or recommend either fund. Past performance does not indicate future returns; mutual fund investments are subject to market risks.